Platelet to Lymphocyte Ratio as a Predictor of Infarct-Related Artery Patency in Patients Undergoing Primary Percutaneous Coronary Intervention

Abdalla Mostafa Kamal; Mona Fikry Fathy; Ghada Mahmoud Soltan

doi:doi:10.11648/j.ccr.20210502.12

| Peer-Reviewed

Platelet to Lymphocyte Ratio as a Predictor of Infarct-Related Artery Patency in Patients Undergoing Primary Percutaneous Coronary Intervention

Abdalla Mostafa Kamal, Mona Fikry Fathy, Ghada Mahmoud Soltan

Published in Cardiology and Cardiovascular Research (Volume 5, Issue 2)

Received: 15 April 2021 Accepted: 3 May 2021 Published: 14 May 2021

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Background: In myocardial infarction (MI) patients, myocardial reperfusion and subsequently, early infarct related artery (IRA) patency are very critical in this emergency situation. Recently, there is growing research on the ability of platelet to lymphocyte ratio (PLR) to be a predictor of outcome and its value as a marker for inflammation and coagulopathy detection. Our work aims at finding the relation between PLR and the prognosis of IRA in STEMI patients. Methodology: Two hundred cases presented with STEMI were included for the study. Patency of IRA was estimated by Thrombolysis in Myocardial Infarction (TIMI) grade. Patent IRA was defined as TIMI grade III flow and occluded IRA was defined as TIMI grade 0-II flow. Blood samples were withdrawn on admission at emergency department to calculate PLR. Results: Forty-one (20.5%) cases revealed TIMI 3 flow in IRA before pPCI. Occluded group showed significantly higher PLR than patent group with mean PLR 231.3±94.2 vs 100.95±37.7 respectively with P value <0.0001. Multivariate regression analysis demonstrated, both HTN [95% CI (- 0.135)-(-0.747)] & PLR ratio [95% CI (-0.001)-(-0.002)] together are the most independent predictors for TIMI flow in IRA (F-ratio=12.2, p<0.001). Conclusion: our results show that high Platelet lymphocyte ratio predicts patency of IRA independently in cases with STEMI before pPCI.

Published in	Cardiology and Cardiovascular Research (Volume 5, Issue 2)
DOI	10.11648/j.ccr.20210502.12
Page(s)	61-66
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2021. Published by Science Publishing Group

Keywords

PLR, IRA, pPCI

References

[1]	Maseri A, Fuster V. Is there a vulnerable plaque? Circulation. 2003; 107 (16): 2068-2071.
[2]	Fuentes QE, Fuentes QF, Andres V, Pello OM, Font de Mora J, Palomo GI. Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis. Platelets. 2013; 24 (4): 255-262.
[3]	Zeymer U, Huber K, Fu Y, et al. Impact of TIMI 3 patency before primary percutaneous coronary intervention for ST-elevation myocardial infarction on clinical outcome: results from the ASSENT-4 PCI study. Eur Heart J Acute Cardiovasc Care. 2012; 1 (2): 136–42.
[4]	Brodie BR, Stuckey TD, Hansen C, et al. Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction. Am J Cardiol. 2000; 85 (1): 13-18.
[5]	Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999; 340: 115-26.
[6]	Libby P. What have we learned about the biology of atherosclerosis? The role of inflammation. Am J Cardiol 2001; 88: 3J-6J.
[7]	Gurm HS, Bhatt DL, Gupta R, Ellis SG, Topol EJ, Lauer MS. Preprocedural white blood cell count and death after percutaneous coronary intervention. Am Heart J 2003; 146: 692-8.
[8]	Gillum RF, Mussolino ME, Madans JH. Counts of neutrophils, lymphocytes, and monocytes, cause-specific mortality and coronary heart disease: the NHANES-I epidemiologic follow-up study. Ann Epidemiol 2005; 15: 266-71.
[9]	Klovaite J, Benn M, Yazdanyar S, Nordestgaard BG. High platelet volume and increased risk of myocardial infarction: 39,531 participants from the general population. J Thromb Haemost. 2011; 9 (1): 49-56.
[10]	Ly HQ, Kirtane AJ, Murphy SA, et al. Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials). Am J Cardiol. 2006; 98 (1): 1-5
[11]	Ommen SR, Hammill SC, Gibbons RJ. The relative lymphocyte count predicts death in patients receiving implantable cardioverter defibrillators. Pacing Clin Electrophysiol 2002; 25 (10): 1424–8.
[12]	Arruda-Olson AM, Reeder GS, Bell MR, Weston SA, Roger VL. Neutrophilia predicts death and heart failure after myocardial infarction: a community-based study. Circ Cardiovasc Qual Outcomes 2009; 2 (6): 656–62.
[13]	Yildiz A, Yuksel M, Oylumlu M, Polat N, Akyuz A, Acet H, et al.. The Utility of the Platelet-Lymphocyte Ratio for Predicting No Reflow in Patients With ST-Segment Elevation Myocardial Infarction. Clin Appl Thromb Hemost 2014. http://dx.doi.org/10.1177/1076029613519851 [Epub ahead of print].
[14]	Lang RM, Bierig M, Devereux RB, et al., Chamber Quantification Writing Group, American Society of Echocardiography’s Guidelines and Standards Committee, European Association of Echocardiography, Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology, J Am Soc Echocardiogr, 2005; 18 (12): 1440–63.
[15]	Dogan M, Akyel A, Bilgin M, et al. Can admission neutrophil to lymphocyte ratio predict infarct-related artery patency in STSegment elevation myocardial infarction. Clin Appl Thromb Hemost. 2015; 21 (2): 172-176.
[16]	Nunez J, Nunez E, Bodi V, et al. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment eleation myocardial infarction. Am J Cardiol. 2008; 101 (6): 7.
[17]	Lamas GA, Flaker GC, Mitchell G, et al. Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement Investigators. Circulation. 1995; 92 (5): 1101-1109.
[18]	Mehta RH, Harjai KJ, Cox D, et al. Clinical and angiographic correlates and outcomes of suboptimal coronary flow inpatients with acute myocardial infarction undergoing primary percutaneous coronary intervention. J Am Coll Cardiol. 2003; 42 (10): 1739-1746.
[19]	Stone GW, Cox D, Garcia E, Brodie BR, Morice MC, Griffin J, et al. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation 2001; 104: 636-41.
[20]	D Yıldıray Şahin, M Gür, Z Elbasan; et al. Predictors of preinterventional patency of infarct-related artery in patients with ST-segment elevation myocardial infarction: Importance of neutrophil to lymphocyte ratio and uric acid level. Exp Clin Cardiol 2013; 18 (2): e77-e81.
[21]	Jing Li, Ying Zhou, Yaowen Zhang et al. Admission homocysteine is an independent predictor of spontaneous reperfusion and early infarct-related artery patency before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction. BMC Cardiovascular Disorders (2018) 18: 125.
[22]	Smith RA, Ghaneh P, Sutton R, Raraty M, Campbell F, Neoptolemos JP. Prognosis of Resected Ampullary Adenocarcinoma by Preoperative Serum CA19-9 Levels and Platelet-Lymphocyte Ratio. J Gastrointest Surg 2008; 12: 1422-8.
[23]	Wang D, Yang JX, Cao DY, et al. Preoperative neutrophil-lymphocyte and plateletlymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma. Onco Targets Ther. 2013; 6: 211–6.
[24]	Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002; 105 (9): 1135-1143.
[25]	Bekler A, Gazi E, Yılmaz M et al. Could elevated platelet-lymphocyte ratio predict left ventricular systolic dysfunction in patients with non-ST elevated acute coronary syndrome? Anatol J Cardiol 2015; 15: 385-90.
[26]	Acet H, Ertaş F, Akıl MA et al. Novel predictors of infarct-related artery patency for ST-segment elevation myocardial infarction: Platelet-to-lymphocyte ratio, uric acid, and neutrophil-to-lymphocyte ratio. Anatol J Cardiol 2015; 15: 648-56. DOI: 10.5152/akd.2014.5592.
[27]	Yayla C, Akbog˘a MA, Canpolat U et al. Platelet to Lymphocyte Ratio Canbe a Predictor of Infarct-Related Artery Patency in Patients with ST-Segment Elevation Myocardial Infarction. Angiology. 2015 Oct; 66 (9): 831-6. doi: 10.1177/0003319715573658.

Cite This Article

Plain Text BibTeX RIS

APA Style

Abdalla Mostafa Kamal, Mona Fikry Fathy, Ghada Mahmoud Soltan. (2021). Platelet to Lymphocyte Ratio as a Predictor of Infarct-Related Artery Patency in Patients Undergoing Primary Percutaneous Coronary Intervention. Cardiology and Cardiovascular Research, 5(2), 61-66. https://doi.org/10.11648/j.ccr.20210502.12

Copy | Download

ACS Style

Abdalla Mostafa Kamal; Mona Fikry Fathy; Ghada Mahmoud Soltan. Platelet to Lymphocyte Ratio as a Predictor of Infarct-Related Artery Patency in Patients Undergoing Primary Percutaneous Coronary Intervention. Cardiol. Cardiovasc. Res. 2021, 5(2), 61-66. doi: 10.11648/j.ccr.20210502.12

Copy | Download

AMA Style

Abdalla Mostafa Kamal, Mona Fikry Fathy, Ghada Mahmoud Soltan. Platelet to Lymphocyte Ratio as a Predictor of Infarct-Related Artery Patency in Patients Undergoing Primary Percutaneous Coronary Intervention. Cardiol Cardiovasc Res. 2021;5(2):61-66. doi: 10.11648/j.ccr.20210502.12

Copy | Download

@article{10.11648/j.ccr.20210502.12,
  author = {Abdalla Mostafa Kamal and Mona Fikry Fathy and Ghada Mahmoud Soltan},
  title = {Platelet to Lymphocyte Ratio as a Predictor of Infarct-Related Artery Patency in Patients Undergoing Primary Percutaneous Coronary Intervention},
  journal = {Cardiology and Cardiovascular Research},
  volume = {5},
  number = {2},
  pages = {61-66},
  doi = {10.11648/j.ccr.20210502.12},
  url = {https://doi.org/10.11648/j.ccr.20210502.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ccr.20210502.12},
  abstract = {Background: In myocardial infarction (MI) patients, myocardial reperfusion and subsequently, early infarct related artery (IRA) patency are very critical in this emergency situation. Recently, there is growing research on the ability of platelet to lymphocyte ratio (PLR) to be a predictor of outcome and its value as a marker for inflammation and coagulopathy detection. Our work aims at finding the relation between PLR and the prognosis of IRA in STEMI patients. Methodology: Two hundred cases presented with STEMI were included for the study. Patency of IRA was estimated by Thrombolysis in Myocardial Infarction (TIMI) grade. Patent IRA was defined as TIMI grade III flow and occluded IRA was defined as TIMI grade 0-II flow. Blood samples were withdrawn on admission at emergency department to calculate PLR. Results: Forty-one (20.5%) cases revealed TIMI 3 flow in IRA before pPCI. Occluded group showed significantly higher PLR than patent group with mean PLR 231.3±94.2 vs 100.95±37.7 respectively with P value <0.0001. Multivariate regression analysis demonstrated, both HTN [95% CI (- 0.135)-(-0.747)] & PLR ratio [95% CI (-0.001)-(-0.002)] together are the most independent predictors for TIMI flow in IRA (F-ratio=12.2, p<0.001). Conclusion: our results show that high Platelet lymphocyte ratio predicts patency of IRA independently in cases with STEMI before pPCI.},
 year = {2021}
}

Copy | Download

TY - JOUR
T1 - Platelet to Lymphocyte Ratio as a Predictor of Infarct-Related Artery Patency in Patients Undergoing Primary Percutaneous Coronary Intervention
AU - Abdalla Mostafa Kamal
AU - Mona Fikry Fathy
AU - Ghada Mahmoud Soltan
Y1 - 2021/05/14
PY - 2021
N1 - https://doi.org/10.11648/j.ccr.20210502.12
DO - 10.11648/j.ccr.20210502.12
T2 - Cardiology and Cardiovascular Research
JF - Cardiology and Cardiovascular Research
JO - Cardiology and Cardiovascular Research
SP - 61
EP - 66
PB - Science Publishing Group
SN - 2578-8914
UR - https://doi.org/10.11648/j.ccr.20210502.12
AB - Background: In myocardial infarction (MI) patients, myocardial reperfusion and subsequently, early infarct related artery (IRA) patency are very critical in this emergency situation. Recently, there is growing research on the ability of platelet to lymphocyte ratio (PLR) to be a predictor of outcome and its value as a marker for inflammation and coagulopathy detection. Our work aims at finding the relation between PLR and the prognosis of IRA in STEMI patients. Methodology: Two hundred cases presented with STEMI were included for the study. Patency of IRA was estimated by Thrombolysis in Myocardial Infarction (TIMI) grade. Patent IRA was defined as TIMI grade III flow and occluded IRA was defined as TIMI grade 0-II flow. Blood samples were withdrawn on admission at emergency department to calculate PLR. Results: Forty-one (20.5%) cases revealed TIMI 3 flow in IRA before pPCI. Occluded group showed significantly higher PLR than patent group with mean PLR 231.3±94.2 vs 100.95±37.7 respectively with P value <0.0001. Multivariate regression analysis demonstrated, both HTN [95% CI (- 0.135)-(-0.747)] & PLR ratio [95% CI (-0.001)-(-0.002)] together are the most independent predictors for TIMI flow in IRA (F-ratio=12.2, p<0.001). Conclusion: our results show that high Platelet lymphocyte ratio predicts patency of IRA independently in cases with STEMI before pPCI.
VL - 5
IS - 2
ER -

Copy | Download

Author Information

Abdalla Mostafa Kamal

Cardiology Department, Faculty of Medicine, Menofia University, Al Minufya, Egypt
Mona Fikry Fathy

Cardiology Department, National Heart Institute, Cairo, Egypt
Ghada Mahmoud Soltan

Cardiology Department, Faculty of Medicine, Menofia University, Al Minufya, Egypt

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Abdalla Mostafa Kamal, Mona Fikry Fathy, Ghada Mahmoud Soltan. (2021). Platelet to Lymphocyte Ratio as a Predictor of Infarct-Related Artery Patency in Patients Undergoing Primary Percutaneous Coronary Intervention. Cardiology and Cardiovascular Research, 5(2), 61-66. https://doi.org/10.11648/j.ccr.20210502.12

Copy | Download

ACS Style

Abdalla Mostafa Kamal; Mona Fikry Fathy; Ghada Mahmoud Soltan. Platelet to Lymphocyte Ratio as a Predictor of Infarct-Related Artery Patency in Patients Undergoing Primary Percutaneous Coronary Intervention. Cardiol. Cardiovasc. Res. 2021, 5(2), 61-66. doi: 10.11648/j.ccr.20210502.12

Copy | Download

AMA Style

Abdalla Mostafa Kamal, Mona Fikry Fathy, Ghada Mahmoud Soltan. Platelet to Lymphocyte Ratio as a Predictor of Infarct-Related Artery Patency in Patients Undergoing Primary Percutaneous Coronary Intervention. Cardiol Cardiovasc Res. 2021;5(2):61-66. doi: 10.11648/j.ccr.20210502.12

Copy | Download

@article{10.11648/j.ccr.20210502.12,
  author = {Abdalla Mostafa Kamal and Mona Fikry Fathy and Ghada Mahmoud Soltan},
  title = {Platelet to Lymphocyte Ratio as a Predictor of Infarct-Related Artery Patency in Patients Undergoing Primary Percutaneous Coronary Intervention},
  journal = {Cardiology and Cardiovascular Research},
  volume = {5},
  number = {2},
  pages = {61-66},
  doi = {10.11648/j.ccr.20210502.12},
  url = {https://doi.org/10.11648/j.ccr.20210502.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ccr.20210502.12},
  abstract = {Background: In myocardial infarction (MI) patients, myocardial reperfusion and subsequently, early infarct related artery (IRA) patency are very critical in this emergency situation. Recently, there is growing research on the ability of platelet to lymphocyte ratio (PLR) to be a predictor of outcome and its value as a marker for inflammation and coagulopathy detection. Our work aims at finding the relation between PLR and the prognosis of IRA in STEMI patients. Methodology: Two hundred cases presented with STEMI were included for the study. Patency of IRA was estimated by Thrombolysis in Myocardial Infarction (TIMI) grade. Patent IRA was defined as TIMI grade III flow and occluded IRA was defined as TIMI grade 0-II flow. Blood samples were withdrawn on admission at emergency department to calculate PLR. Results: Forty-one (20.5%) cases revealed TIMI 3 flow in IRA before pPCI. Occluded group showed significantly higher PLR than patent group with mean PLR 231.3±94.2 vs 100.95±37.7 respectively with P value <0.0001. Multivariate regression analysis demonstrated, both HTN [95% CI (- 0.135)-(-0.747)] & PLR ratio [95% CI (-0.001)-(-0.002)] together are the most independent predictors for TIMI flow in IRA (F-ratio=12.2, p<0.001). Conclusion: our results show that high Platelet lymphocyte ratio predicts patency of IRA independently in cases with STEMI before pPCI.},
 year = {2021}
}

Copy | Download